ONCOLYTICS BIOTECH INC (ONCY)
↓ Download CSV| Metric (FY) | 2025 | 2024 | 2023 |
|---|---|---|---|
| Operating Income | -$28.73M | -$25.54M | — |
| Net Income | -$28.76M | -$22.79M | — |
| EPS (Diluted) | $-0.30 | $-0.30 | — |
| Total Assets | $7.58M | $13.42M | — |
| Total Liabilities | $11.38M | $10.12M | — |
| Shareholders' Equity | -$3.80M | $3.30M | $19.60M |
| Cash & Equivalents | $5.20M | $11.08M | — |
| Operating Cash Flow | -$20.11M | -$19.88M | — |
| Capital Expenditures | $6.0K | $174.0K | — |
| Shares Outstanding | 108.02M | 80.02M | — |